...
首页> 外文期刊>Kidney International Reports >MON-195 TO STUDY CORRELATION OF NAIL CREATININE WITH SERUM CREATININE IN CHRONIC KIDNEY DISEASE STAGE Vd & IN RENAL TRANPLANT RECIPIENT.
【24h】

MON-195 TO STUDY CORRELATION OF NAIL CREATININE WITH SERUM CREATININE IN CHRONIC KIDNEY DISEASE STAGE Vd & IN RENAL TRANPLANT RECIPIENT.

机译:MON-195研究慢性肾脏病阶段与肾移植受体中指甲油和血清肌酐的相关性。

获取原文
           

摘要

Pauci Immune Glomerulonephritis is the most common cause of rapidly progressive glomerulonephritis. Standard treatment for ANCA associated vasculitis consists of combined use of cyclophosphamide and steroids. Although this treatment had dramati- cally changed the prognosis, 20% of patients with AAV will develop ESRD during their lifetime’ Kidney Transplantation improves both the life expectancy and quality of life in patients with ESRD. For patients with ANCA vasculitis, both the KDIGO and Canadian society of trans- plantation recommend that AAV patients should be in clinical remission for 1 year prior to proceeding for transplantation. ANCA positivity is not acontraindication for transplantation, however it has been reported that patients with ANCA positivity more likely to develop severe vasculop- athy in graft and recurrence of vasculitis in allograft. Rate of recurrence of ANCA vasculitis in the post transplantation period is variable ranging from 1.6%-17.3%. The higher rate of recurrence was reported in patients receiving prednisone, cyclosporine and azathioprine for immunosup- pression, whereas with the current tacrolimus and mycophenolate regi- mens, the rate of relapse in much lower. Average time to recurrence in the above studies was 20 months to 68 months post transplant. Our patient had recurrence of vasculitis day 5 after transplantation despite aggressive induction immunosuppression.
机译:丘脑免疫性肾小球肾炎是迅速进行性肾小球肾炎的最常见原因。 ANCA相关性血管炎的标准治疗方法是联合使用环磷酰胺和类固醇。尽管这种治疗显着改变了预后,但20%的AAV患者将在其一生中发展为ESRD。肾脏移植可改善ESRD患者的预期寿命和生活质量。对于ANCA血管炎患者,KDIGO和加拿大移植学会均建议AAV患者在进行移植前应临床缓解1年。 ANCA阳性并不是移植的禁忌症,但是据报道,ANCA阳性的患者更有可能在移植物中形成严重的血管炎,同种异体血管炎复发。移植后ANCA血管炎的复发率在1.6%-17.3%之间变化。据报道,接受泼尼松,环孢霉素和硫唑嘌呤进行免疫抑制的患者复发率较高,而目前使用他克莫司和霉酚酸酯治疗的患者复发率要低得多。上述研究中平均复发时间为移植后20个月至68个月。尽管进行了积极的诱导免疫抑制,我们的患者在移植后第5天就复发了血管炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号